| ¿µ¹® | german measles | ÇÑ±Û | dzÁø |
|---|---|---|---|
| ¼³¸í | Rubella, ¶Ç´Â '3ÀÏ È«¿ª'À̶ó°í ºÒ¸®´Â ÀÌ º´Àº dzÁø¹ÙÀÌ·¯½ºÀÇ °¨¿°¿¡ ÀÇÇÑ º´À¸·Î ÁÖ·Î ¼Ò¾Æ±â¿¡ ÈçÇÑ Áúº´ÀÌ´Ù. Àü¿°¼ºÀÌ ¾ÆÁÖ °ÇÏ°í ¼ºÀα⿡ °É·ÈÀ» °æ¿ì¿¡´Â ÀϹÝÀûÀ¸·Î ¼Ò¾Æ±â¶§º¸´Ù Áõ»óÀÌ ½ÉÇÏ´Ù. dzÁø¹ÙÀÌ·¯½ºÀÎ Togaviridae familyÀÇ Rubivirus¶ó´Â Á¾¿¡ ÀÇÇÏ¿© »ý±ä´Ù. Àü¿°¹æ½ÄÀº ±âħÀ̳ª Àçä±â ¶Ç´Â ¸»ÇÒ ¶§ Æ¢¾î ³ª¿À´Â ħ¿¡ ¼¯¿© ÀÖ´Â ÀÛÀº ¹ÙÀÌ·¯½º ÀÔÀÚ·Î ÀüÆÄµÈ´Ù. Àӽźΰ¡ dzÁø¿¡ °¨¿°µÇ¸é ŹÝÀ» ÅëÇÏ¿© žƿ¡ Àü¿°µÈ´Ù. Àẹ±â´Â 14~21ÀÏ(´ë°³ 17ÀÏ) Áõ»óÀº ±× Ư¡¿¡ µû¶ó¼ Àü±¸±â¿Í ¹ßÁø±â·Î ³ª´«´Ù. |
||
| EMO | Epstein-Macintosh-Oxford [inhaler]; exophthalmos, myxedema circumscriptum praetibiale, and osteoarth... |
|---|---|
| DFG | direct forward gaze; German Research Federation [Deutsche Forshungsgemeinschaft] |
| Ger | geriatric(s); German |
| PS | pacemaker syndrome; paired stimulation; paradoxical sleep; paraspinal; parasympathetic; Parkinson sy... |
| stat | immediately [Lat. statim]; radiation emanation unit [German] |
| ORLS | Oxford Record Linkage Study |
|---|---|
| GCP | German Cardio-Vascular-Prevention Study |
| G.D.R. | German Democratic Republic |
| GPO | German Society of Paediatric Oncology |
| CES-D | Center for Epidemiologic Studies - Depression |
| Oxford unit | <microbiology> The minimum amount of penicillin which will prevent the growth of Staphylococcus aureus over an area 26 mm in diameter in a standard culture medium; 1 unit equals 0.6 ug of crystalline sodium salt of penicillin. Synonym: Florey unit. (05 Mar 2000) |
|---|---|
| vaccination, german measles | See Vaccination, MMR. (12 Dec 1998) |
| german | Of or pertaining to Germany. German Baptists. See Dunker. German bit, a wood-boring tool, having a long elliptical pod and a scew point. <zoology> German carp, the crucian carp. <botany> German millet, a character resembling modern German type, used in English printing for ornamental headings, etc, as in the words. German tinder. See Amadou. Origin: L. Germanus. See German. Source: Websters Dictionary (01 Mar 1998) |
| german measles | Rubella is another term for German measles, an acute viral illness that starts as an upper respiratory infection and evolves into a generalised rash. Immunisation is advisable (MMR vaccine). Testing for Rubella antibody titres is performed routinely in pregnant females as a check for German measles immunity. (27 Sep 1997) |
| german measles immunization | The standard MMR vaccine is given to prevent measles, mumps and rubella (German measles). The MMR vaccine is now given in two dosages. The first should be given at12-15 months of age. The second vaccination should be given at 4-6 years (or, alternatively, 11-12 years) of age. most colleges require proof of a second measles or MMR vaccination prior to entrance. Most children should receive MMR vaccinations. Exceptions may include children born with an inability to fight off infection, some children with cancer, on treatment with radiation or drugs for cancer, on long term steroids (cortisone). People with severe allergic reactions to eggs or the drug neomycin should probably avoid the MMR vaccine. Pregnant women should wait until after delivery before being immunised with MMR. People with HIV or AIDS should normally receive MMR vaccine. Measles, mumps, and rubella vaccines may be administered as individual shots, if necessary, or as a measles-rubella combination. (12 Dec 1998) |
| German measles virus | The type (and only) species of rubivirus causing acute infection in humans, primarily children and young adults. Humans are the only natural host. A live, attenuated vaccine is available for prophylaxis. (12 Dec 1998) |
| immunization, german measles | See Immunization, MMR. (12 Dec 1998) |
| retrospective studies | Studies used to test aetiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. (12 Dec 1998) |
| pharmalogical studies | <pharmacology> Studies to assess the potential harmful or other effects of drugs (16 Dec 1997) |
| clinical studies | <pharmacology> Human studies that are designed to measure the safety, efficacy, and appropriate dosage of a new drug or biological. Clinical studies routinely involve the use of a placebo group that is given an inactive substance that looks like the test product. (14 Nov 1997) |
| cohort studies | Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesised to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. (12 Dec 1998) |
| combination studies | <pharmacology> Studies in which a new drug is evaluated in combination with existing drugs. (09 Jan 1998) |
| multicenter studies | Controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children. (12 Dec 1998) |
| multivariate studies | The use of statistical techniques for the simultaneous investigations of the influence of several variables. (05 Mar 2000) |
| preclinical studies | <pharmacology> Studies in which a drug is tested on animals and in other non-human test systems. Safety information from such studies are used to support an investigational new drug application. (14 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|